Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer
Figure 11.The enrichment results of GO and KEGG pathways in the high expression group and the low expression group. (A–D) The enrichment results of GO and KEGG pathways in the high expression group and the low expression group.